Cristian G Beccaria
banner
cristianbeccaria.bsky.social
Cristian G Beccaria
@cristianbeccaria.bsky.social
EMBO Fellow at IannaconeLab | San Raffaele Scientific Institute
B & T cell immunologist 🔬
Poetry lover, kinda musician, WIP photographer, someday filmmaker ❤️‍🔥
Exploring the intersection of science, art, and humanity 🙂
World is for everyone! 🏳️‍🌈✊🏼
So happy to share that our review in #ImmunolRev is finally out! 😃 We discuss how the immune system builds specialized TLSs across organs and conditions. Huge thanks to @StephanGuillaume, @iannaconelab.bsky.social & @linterman.bsky.social for this collaboration!
dx.doi.org/10.1111/imr.70063
Tertiary Lymphoid Structures Across Organs: Context, Composition, and Clinical Levers
Tertiary lymphoid structures (TLSs) arise in non-lymphoid tissues in response to persistent antigen stimulation and chronic inflammation. Spanning organs from lung and liver to meninges, skin, and be...
dx.doi.org
September 25, 2025 at 7:12 PM
Amazing talk by Michelle @linterman.bsky.social at @iuis-online.bsky.social 2025 on ageing and immune responses to vaccines, shedding light on how understanding these mechanisms can guide the development of better immunization strategies
August 22, 2025 at 9:27 AM
Thrilled to share some of the stories we've been working on in our @iannaconelab.bsky.social at #IUIS2025 @iuis-online.bsky.social in Vienna! Excited to chat with so many friends and colleagues from around the world! @davidemarotta.bsky.social @CaitlinAAbbott
August 21, 2025 at 5:23 PM
Reposted by Cristian G Beccaria
What can I say... my watercolor made it to the cover of the latest issue of @natimmunol.nature.com, together with our paper on IL-27 in chronic hep B 🚀 We really put the cherry on top in the @iannaconelab.bsky.social @cristianbeccaria.bsky.social. 🥹💜 Check it out! www.nature.com/ni/volumes/2...
August 1, 2025 at 2:59 PM
Reposted by Cristian G Beccaria
Drs. @valentinavenzin.bsky.social, @cristianbeccaria.bsky.social, and the @iannaconelab.bsky.social identified the molecular and cellular mechanisms by which CD4⁺ #Tcells can restore antiviral CD8⁺ T cell function in the #liver.

@natimmunol.nature.com: go.nature.com/3Ggjajr
🎧: bit.ly/3GP9NaK
July 24, 2025 at 7:04 PM
Excited to share our new work in @Science Translational Med! A collaborative effort exploring RNAi for silencing HBV antigens and rebalancing immunity in chronic hepatitis B.
I hope you enjoy it! and we’re always open to discuss perspectives! :)
Happy to share our latest review "Targeting HBV with RNA interference: Paths to cure"| Science Translational Medicine www.science.org/doi/10.1126/... written together with @cristianbeccaria.bsky.social, Lena Allweiss, Julie Lucifora, John Tavis, Adam Gehring and Maura Dandri
Targeting HBV with RNA interference: Paths to cure
RNA-targeting therapies hold promise for contributing to HBV cure regimens, but challenges remain before that promise can be realized.
www.science.org
July 2, 2025 at 8:23 PM
Thrilled to share our latest publication 😃! Beyond the science and the new paths it opens, working with you @valentinavenzin.bsky.social has been one of the most beautiful and transformative journeys of my life. So proud of what we built together with the whole lab! Hope you enjoy it!
11/ Kudos to @valentinavenzin.bsky.social‬, @cristianbeccaria.bsky.social, all members of the @iannaconelab.bsky.social&collaborators for charting this intrahepatic circuit. Expect Kupffer cell licensing and IL 27 to enter conversations on cancer immunotherapy, vaccines and beyond. Thoughts welcome!
June 30, 2025 at 9:22 AM
This is so awesome! Science’s Breakthrough of the Year, Lenacapavir, an injectable drug that prevents HIV infection for 6 months, shows up to 100% efficacy in trials. A game-changer in PrEP, powered by basic research on HIV. Next... ensuring access worldwide!
www.science.org/content/arti...
Science’s 2024 Breakthrough of the Year: Opening the door to a new era of HIV prevention
A drug with a novel mechanism protects people against the AIDS virus for 6 months. It could speed the end of the epidemic—if those who need it most get access
www.science.org
December 13, 2024 at 8:43 PM
One year under Milei, Argentina’s science faces collapse. Budget cuts, brain drain, and ideological censorship are dismantling a system that once thrived despite challenges. Researchers are leaving, projects are halted... Its so so sad

www.nature.com/articles/d41...
‘There will be nothing left’: researchers fear collapse of science in Argentina
One year into Javier Milei’s presidency, scientists are exiting the country in the face of big budget cuts.
www.nature.com
December 11, 2024 at 9:30 PM
Reposted by Cristian G Beccaria
If an #H5N1 pandemic starts tomorrow or in three months, there will be little mystery as to how it happened. The conditions are all there. They have been for a while.
So in some ways the more interesting question to me at the moment is: Why aren’t we in a pandemic yet?
Story here, 🧵 to come:
🧪#IDSky
Why hasn’t the bird flu pandemic started?
Some scientists examining mutations found in H5N1 viruses fear major outbreak is imminent but others says pathogen remains unpredictable
www.science.org
December 6, 2024 at 12:54 PM
Science could solve some of the world’s biggest problems. Why aren’t governments using it?
www.nature.com/articles/d41...
Science is key to tackling global challenges, yet there's still a gap between researchers and policymakers in addressing issues like pandemics, climate change, and health crises
Science could solve some of the world’s biggest problems. Why aren’t governments using it?
A Nature global survey finds that most specialists are unhappy with systems to provide science advice to policymakers.
www.nature.com
December 5, 2024 at 3:16 PM
So happy and excited to be here and connect with all of you in this space 😃 ! Looking forward to sharing insights on #immunology in the #Immunosky, #research, and our shared journey through #science, #art, and #humanity, away from misinformation, hatters, and monetization-driven algorithms !
November 21, 2024 at 8:58 PM